(Video length 00:02:29)
Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat Wall Street’s expectations, led by higher sales in its medical-device unit and higher demand for some of its drugs. Joseph Wolk, executive vice president, and chief financial officer at Johnson & Johnson, joins “Squawk Box” to discuss the quarter and the company’s outlook.



Comments
Log in or sign up to join the conversation.